High Tower Advisors, LLC In8 Bio, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 10,000 shares of INAB stock, worth $21,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$21,800
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INAB
# of Institutions
29Shares Held
21.7MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$18.7 Million1.8% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$12.4 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.08MShares$4.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$3.93 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.45MShares$3.16 Million0.13% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $53.4M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...